help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online Data Supplement
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shekerdemian, L. S.
Right arrow Articles by Penny, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shekerdemian, L. S.
Right arrow Articles by Penny, D. J.

Am. J. Respir. Crit. Care Med., Volume 165, Number 8, April 2002, 1098-1102

Intravenous Sildenafil Lowers Pulmonary Vascular Resistance in a Model of Neonatal Pulmonary Hypertension

Lara S. Shekerdemian, Hanne B. Ravn, and Daniel J. Penny

Department of Cardiac Intensive Care, Great Ormond Street Hospital, London, United Kingdom; and Department of Anaesthesia and Intensive Care and Institute of Experimental Clinical Research, Aarhus University Hospital, Aarhus, Denmark

Persistent pulmonary hypertension secondary to meconium aspiration syndrome is an important cause of morbidity and mortality in the neonatal population. We investigated the use of the phosphodiesterase-5 inhibitor sildenafil, in its intravenous form, as a pulmonary vasodilator in a model of meconium aspiration syndrome. Pulmonary hypertension was induced in 18 piglets, by endotracheal instillation of human meconium, 6 piglets subsequently received an infusion of intravenous sildenafil for 2 hours, 6 received inhaled nitric oxide for 2 hours, and 6 control animals received no additional intervention. Meconium aspiration increased pulmonary vascular resistance by 70%, and increased oxygenation index by over 100%. Pulmonary vascular resistance remained elevated for the remainder of the study period in control animals. Inhaled nitric oxide reduced the pulmonary vascular resistance by 40% after 2 hours of treatment; intravenous sildenafil completely reversed the increase in pulmonary vascular resistance within 1 hour of commencing the infusion. Neither agent had an effect on systemic hemodynamics. Sildenafil also increased cardiac output by 30%, but while doing so did not adversely influence oxygenation. Intravenous sildenafil is a selective and highly effective pulmonary vasodilator, which is at least as effective as inhaled nitric oxide, in this model of neonatal persistent pulmonary hypertension.




This article has been cited by other articles:


Home page
 Journal of Pharmacy PracticeHome page
K. A. Pesaturo, P. N. Johnson, and E. Z. Ramsey
Pediatric Pulmonary Hypertension: A Pharmacotherapeutic Review
Journal of Pharmacy Practice, April 1, 2009; 22(2): 166 - 178.
[Abstract] [PDF]

Home page
 CLIN PEDIATRHome page
D. Gamboa, D. Robbins, and Z. Saba
Bleeding After Circumcision in a Newborn Receiving Sildenafil
Clinical Pediatrics, December 1, 2007; 46(9): 842 - 843.
[Abstract] [PDF]

Home page
 Ann. Thorac. Surg.Home page
S. Nemoto, E. Umehara, T. Ikeda, T. Itonaga, and M. Komeda
Oral Sildenafil Ameliorates Impaired Pulmonary Circulation Early After Bidirectional Cavopulmonary Shunt
Ann. Thorac. Surg., May 1, 2007; 83(5): e11 - e13.
[Abstract] [Full Text] [PDF]

Home page
 NeoReviewsHome page
R. H Steinhorn and K. N Farrow
Pulmonary Hypertension in the Neonate
NeoReviews, January 1, 2007; 8(1): e14 - e21.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
M. Martell, F. Blasina, F. Silvera, S. Tellechea, C. Godoy, L. Vaamonde, L. Benenatti, and W. Olivera
Intratracheal Sildenafil in the Newborn With Pulmonary Hypertension
Pediatrics, January 1, 2007; 119(1): 215 - 216.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
P. Namachivayam, U. Theilen, W. W. Butt, S. M. Cooper, D. J. Penny, and L. S. Shekerdemian
Sildenafil Prevents Rebound Pulmonary Hypertension after Withdrawal of Nitric Oxide in Children
Am. J. Respir. Crit. Care Med., November 1, 2006; 174(9): 1042 - 1047.
[Abstract] [Full Text] [PDF]

Home page
 NeoReviewsHome page
D. W. Kays
Congenital Diaphragmatic Hernia: Real Improvements in Survival
NeoReviews, August 1, 2006; 7(8): e428 - e439.
[Full Text] [PDF]

Home page
 PediatricsHome page
H. Baquero, A. Soliz, F. Neira, M. E. Venegas, and A. Sola
Oral Sildenafil in Infants With Persistent Pulmonary Hypertension of the Newborn: A Pilot Randomized Blinded Study
Pediatrics, April 1, 2006; 117(4): 1077 - 1083.
[Abstract] [Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
D. A Calhoun, S N. Murthy, B. G Bryant, S. A Luedtke, and V. Bhatt-Mehta
Recent Advances in Neonatal Pharmacotherapy
Ann. Pharmacother., April 1, 2006; 40(4): 710 - 719.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child. Fetal Neonatal Ed.Home page
M Chaudhari, M Vogel, C Wright, J Smith, and S G Haworth
Sildenafil in neonatal pulmonary hypertension due to impaired alveolarisation and plexiform pulmonary arteriopathy
Arch. Dis. Child. Fetal Neonatal Ed., November 1, 2005; 90(6): F527 - F528.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
C. A. Dias-Junior, D. C. Souza-Costa, T. Zerbini, J. B. T. da Rocha, R. F. Gerlach, and J. E. Tanus-Santos
The Effect of Sildenafil on Pulmonary Embolism-Induced Oxidative Stress and Pulmonary Hypertension
Anesth. Analg., July 1, 2005; 101(1): 115 - 120.
[Abstract] [Full Text] [PDF]

Home page
 Br J AnaesthHome page
J. Ng, S. J. Finney, R. Shulman, G. J. Bellingan, M. Singer, and P. A. Glynne
Treatment of pulmonary hypertension in the general adult intensive care unit: a role for oral sildenafil?
Br. J. Anaesth., June 1, 2005; 94(6): 774 - 777.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
B. Larrue, S. Jaillard, M. Lorthioir, X. Roubliova, G. Butrous, T. Rakza, H. Warembourg, and L. Storme
Pulmonary vascular effects of sildenafil on the development of chronic pulmonary hypertension in the ovine fetus
Am J Physiol Lung Cell Mol Physiol, June 1, 2005; 288(6): L1193 - L1200.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Ophthalmol.Home page
C S Marsh, B Marden, and R Newsom
Severe retinopathy of prematurity (ROP) in a premature baby treated with sildenafil acetate (Viagra) for pulmonary hypertension
Br. J. Ophthalmol., February 1, 2004; 88(2): 306 - 307.
[Full Text]

Home page
 Am. J. Respir. Crit. Care Med.Home page
R. T. Schermuly, K. P. Kreisselmeier, H. A. Ghofrani, H. Yilmaz, G. Butrous, L. Ermert, M. Ermert, N. Weissmann, F. Rose, A. Guenther, et al.
Chronic Sildenafil Treatment Inhibits Monocrotaline-induced Pulmonary Hypertension in Rats
Am. J. Respir. Crit. Care Med., January 1, 2004; 169(1): 39 - 45.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
T. Itoh, N. Nagaya, T. Fujii, T. Iwase, N. Nakanishi, K. Hamada, K. Kangawa, and H. Kimura
A Combination of Oral Sildenafil and Beraprost Ameliorates Pulmonary Hypertension in Rats
Am. J. Respir. Crit. Care Med., January 1, 2004; 169(1): 34 - 38.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
L. Foubert, D. De Wolf, K. Reyntjens, Y. Van Belleghem, F. De Somer, G. Van Nooten, and E. Mortier
Intermittent Nitric Oxide Combined with Intravenous Dipyridamole in a Piglet Model of Acute Pulmonary Hypertension
Anesth. Analg., November 1, 2003; 97(5): 1497 - 1500.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. J. Tobin
Pediatrics, Surfactant, and Cystic Fibrosis in AJRCCM 2002
Am. J. Respir. Crit. Care Med., February 1, 2003; 167(3): 333 - 344.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. J. Tobin
Chronic Obstructive Pulmonary Disease, Pollution, Pulmonary Vascular Disease, Transplantation, Pleural Disease, and Lung Cancer in AJRCCM 2002
Am. J. Respir. Crit. Care Med., February 1, 2003; 167(3): 356 - 370.
[Full Text] [PDF]

Home page
 BMJHome page
J. Oliver, D. J Webb, S. Patole, and J. Travadi
Sildenafil for "blue babies"
BMJ, November 16, 2002; 325(7373): 1174 - 1174.
[Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2002 American Thoracic Society 		  Tobacco